Abstract Deleterious invasiveness of glioma cells into the normal brain tissue is endorsed by its inherent ability to regulate the receptor-mediated adhesive properties, extracellular matrix degradation and remodeling and elevated secretory ability of metalloproteinase (MMPs) such as MMP-2. By doing so, it will create an intercellular space for the invasion of glioma cells. Here, we reported that combination of gene therapy Buthus martensii Karsch (BmK) CT, a type of scorpion toxin peptide, with lithium chloride (LiCl), clinically used as mood stabilizer, could inhibit the migration and invasion of C6 glioma cells. The results showed that concomitant administration of LiCl and pEGFP-N1-BmK CT on glioma cells would hamper pro-MMP2 secretion and in the meantime, inhibited its proliferation in a synergistic manner. These results try to extrapolate the potential interplay between the combined treatment of LiCl and BmK CT with signaling pathways b-catenin, MMP, GSK-3 in C6 glioma cells. This strategy can stand for a novel approach designated for the development of a new method for glioma therapy.
Introduction
Glioma is the most common type of human brain tumors. Traditional therapy of brain tumors includes surgery, radiation therapy, chemotherapy, and immunotherapy . Despite these intense treatments, contemporary median survival time is still less than 15 months (Demuth and Berens 2004) . It is clear that some adjuvant treatment will lead to newer and more effective methods and strategies for treating glioma.
BmK CT, isolated from the venom gland of Buthus martensii Karsch, is a 36 mer peptide cross-linked by four disulfide bridges. Its sequence identity is 68 % similar to CTX isolated from the scorpion Leiurus quinquestriatus (DeBin et al. 1993) . BmK CT was characterized as a novel blocker of the chloride ion channel and matrix metalloproteinase-2 (MMP-2) of glioma cells ). MMPs are a family of endopeptidases that have the capacity to degrade all components of the extracellular matrix. Tumor-secreted metalloproteinases (MMPs) such as MMP-2, can degrade and remodel of extracellular matrix and thus create an intercellular space for invasion of glioma cells. So MMP-2 activity is essential for the invasion of glioma cells (Deshane et al. 2003) .
LiCl has been used clinically as therapeutic agents in treating bipolar disorder (Feinstein 1998; Kagaya et al. 2000) and was recently proven efficient in inhibiting glioma cell migration and invasion. Other reported work showed that a high concentration of LiCl (20 mM) was required to obtain significant inhibitory effects on the migration ability of glioma cell (Nowicki et al. 2008 ). But LiCl is often toxic at high concentrations, thus limiting its application as a therapeutic agent against gliomas (Markovic et al. 2005) .
In our previous report, we confirmed that there were potential therapeutic benefits of the simultaneous administration of LiCl and BmK CT for the treatment of gliomas (Fu et al. 2012) . In this study, the effect of LiCl and gene therapy pEGFP-N1-BmK CT on glioma cells was studied and we analyzed the mechanism that might explain the inhibitory effect of combination therapy on glioma migration.
Materials and methods

Materials
pEGFP-N1-BmK CT was constructed in our laboratory (Fu et al. 2013) . Rat C6 glioma cells were kindly provided by Prof. Wang (Institute of Clinical Medicine, Renmin Hospital, Yunyang Medical College, Shiyan, Hubei, China). Dulbecco's modified Eagle's medium (DMEM) was obtained from Gibco BRL. Calf serum was from Hangzhou Evergreen Corp. (Hangzhou, China). Lipofectamine 2000 was from Invitrogen (Carlsbad, CA, USA). Gelatin and Triton X-100 were purchased from Sigma-Aldrich (St. Louis, MO, USA). The rabbit-anti b-catenin antibody was purchased from Wuhan Boster Biological Technology Corp (Wuhan, China). Rabbit-anti-rat b-actin was purchased from Sangon Biotech Corp (Shanghai, China). All reagents used were of highest molecular grade.
Cell culture
Cell cultures were prepared and maintained according to standard cell culture procedures. The rat C6 glioma cells were cultured at 37°C in a humidified atmosphere of 5 % CO 2 in DMEM supplemented with 10 % (v/v) heat-inactivated calf serum.
Transfection of recombinant plasmids C6 glioma cells were cultured in the 6-, 24-, and 96-well microtiter plates for Western blot assay, colorimetric 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, gelatin zymography assay and in vitro wound healing assay, respectively. 
MTT assay
The effect of LiCl on cell growth was examined by MTT assay. This assay is based on the cellular conversion of a tetrazolium salt into a formazan product that was easily detected using 96-well plate reader. Therefore, the MTT assay is a simple and sensitive method to study cellular survival and cellular growth, cytotoxicity, cell attachment and apoptosis. Equivalent number of C6 glioma cells (10 4 cells well
) was added to a 96-well microtiter plate, followed by adding the medium to give the final volume of 100 ll. Then, the untreated cells served as control, or cells were transfected with pEGFP-N1, pEGFP-N1-BmK CT and treated with LiCl for 24 h, respectively. Then tetrazolium salt was added to each well and the cells were further incubated for 4 h, the media were discarded and DMSO (150 ll) was added to each well. The absorbance at 490 nm of each well was recorded using a microplate reader (Bio-Rad 550, Hercules, CA, USA). Inhibition rate (IR) was calculated according to the following equation: IR (%) = (C -T)/C 9 100 %, where T and C represented the mean optical density of the treated sample and the control, respectively. Experiments were performed three times and the average values ±SD were recorded.
Gelatin zymography assay
Gelatinolytic activity of MMP-2 was analyzed by gelatin zymography assay. C6 cells transfected with recombinant plasmids (pEGFP-N1, pEGFP-N1-BmK CT) were incubated for 24 h and then treated with LiCl for 24 h. Culture media were then replaced by serum-free cell culture media. Serum-free media conditioned for 24 h were subjected to 10 % (v/v) SDS-PAGE (containing 0.1 % gelatin) electrophoresis analysis. The gel was incubated twice (for 30 min at room temperature) in 2.5 % Triton X-100. The gel was then incubated in activation buffer (5 mM CaCl 2 , 1 mM ZnCl 2 , and 0.005 % Brij, 50 mM Tris/HCl, pH 8.0) at 37°C overnight, stained with Coomassie Brilliant Blue R-250 and briefly destained in 10 % (v/v) acetic acid and 40 % (v/v) methanol. Gelatinolytic activity of MMPs was detected as transparent bands on the blue background.
Cell harvesting and protein fractionation
Preparation of total and nuclear protein was conducted as previously described. Briefly, the transfectants harboring pEGFP-N1, pEGFP-N1-BmK CT were treated with LiCl for 24 h to prepare whole-cell lysates by centrifugation and lysed in 100 ll of RIPA buffer (Sangon Biotech, Shanghai, China). For nuclear protein extraction, cells were washed with PBS, resuspended in 350 ll of buffer A (20 mM HEPES, pH 7.5, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, and 1.5 mM Phenylmethanesulfonyl fluoride (Sangon Biotechn Corp, Shanghai, China), and incubated on ice for 15 min. Then NP-40 was added to a final concentration of 1 % (v/v) and vortexed for 1 min, followed by centrifugation for 10 min at 4°C at 1,6009g. The supernatant of the cytosolic fraction was transferred to a new tube. The nuclear pellet was washed with 400 ll of buffer A, pelleted for 10 min at 4°C at 1,6009g and then solubilized by addition of one pellet volume of NE buffer (20 mM Tris, pH 8.0, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25 % glycerol, and 1.5 mM Phenylmethanesulfonyl fluoride (Sangon Biotechn Corp, Shanghai, China). After that, one-fourth pellet volume of NaCl (5 M) and one pellet volume of NE buffer were added and then vortexed.
Western blot analysis
The protein concentration was determined by BCA assay and the samples were analyzed by electrophoresis using SDS-PAGE gel (10 % w/v). Western blot analysis was conducted by blotting onto the nitrocellulose membrane (Millipore, Billerica, MA, USA). Blots were blocked, incubated with the primary antibodies (anti-b-catenin (Wuhan Boster Biological Technology, China), 1:100 or anti-b-actin (Sangon Biotech, China), 1:500), and washed three times with PBS buffer containing 0.04 % (v/v) Tween-20. Blots were incubated with secondary antibody goat antirabbit IgG-HRP (Boster Biological Technology, Wuhan, China) (diluted at 1:2,000) for 1 h, washed with PBS buffer containing 0.04 % (v/v) Tween-20 three times and then developed using ECL kit (Amersham, Pittsburgh, PA, USA).
In vitro wound healing assay
The effect of LiCl on C6 glioma cell migration was examined using in vitro wound healing assay. After transfection with recombinant plasmids for 24 h and treated with LiCl for 24 h, a 'scratch' was introduced by scraping the C6 glioma cells monolayer with a sterile 200 ll pipette tip and then washed gently twice with cell culture medium to remove cell debris. The cells were then cultured by serum-free culture medium. Percent migration rate (MR %) was calculated as: MR % = (1 -T/C) 9 100 %, where T and C represent the scrape distance at the indicated treatment times and at the previous treatment time, respectively.
Results
Lithium chloride improved the inhibition of proliferation of pEGFP-N1-BmK CTtransfected glioma cells
MTT assay was performed to determine the effect of LiCl on tumor growth. In general, LiCl, an inhibitor of GSK-3b, could inhibit the cell proliferative activity. As shown in Fig. 1 , after transfection with pEGFP-N1-BmK CT for 24 h and treatment with LiCl for 24 h, the growth inhibitory effects of pEGFP-N1-BmK CT was enhanced by LiCl treatment. In both assays, the inhibition rate of the combination treatment of pEGFP-N1-BmK CT and LiCl were elevated compared with that of pEGFP-N1 and LiCl treatment. We proposed that BmK CT could, to some degree, diminish the side effects of LiCl in curbing the metastatic spread of glioma cells.
Effect of combination treatment on pro-MMP-2 activity in C6 glioma cells As shown in Fig. 2 , pro-MMP-2 was detected in the gelatin zymography assay. In the EGFP transfection group, the secretion level of pro-MMP-2 was gradually elevated by the treatment with LiCl, and this elevation was depended on the LiCl concentration. The activity of pro-MMP-2 was suppressed in the EGFP-BmK CT and LiCl treatment group. According to our previous work, we presumed that LiCl induced inactivation of GSK-3b could activate the Wnt/bcatenin pathway, which would induce the expression of MMP-2 (Fu et al. 2014 ).
Combination treatment inhibited C6 glioma cells migration MMP-2 and -9 have been hypothesized to be key enzymes responsible for the degradation of type IV collagen, the main component of extracellular matrix (ECM). These two enzymes may be critical for C6 glioma cells migration or metastasis. As shown in Fig. 3 , migration rates of C6 glioma cells were suppressed in the EGFP and EGFP-BmK CT transfection groups by treatment with LiCl and the inhibition rate in the EGFP-BmK CT and LiCl treatment group was higher than the other treatment group.
Lithium chloride improved the accumulation of bcatenin in C6 glioma cell nucleus As shown in Fig. 4 , after transfection with recombinant plasmids for 24 h and treatment with LiCl for 24 h, the accumulation of b-catenin in the cell nucleus was elevated, and the accumulation of b-catenin was higher in the LiCl-treated C6 cells harboring EGFPBmK CT than that in the C6 cells harboring EGFP.
Discussion
Glioma cancer remains a perplexing challenge for efficient treatment. More effective therapeutic strategies and methods are needed clinically. BmK CT, one of the key toxins in the scorpion Buthus martensii Karsch venom, is a novel blocker of the chloride ion channel and MMP-2 of glioma cells. Matrix metalloproteinases (MMPs) are a family of zinc-dependent endoproteinases involved in the degradation of the extracellular matrix (ECM). LiCl has been used Fig. 1 Effect of lithium chloride and pEGFP-N1-BmK CT on C6 glioma cells proliferation. C6 glioma cells were transfected with pEGFP-N1, pEGFP-N1-BmK CT and then treated with 0-50 mM LiCl. Proliferation assay was performed by MTT test as described in the text. The inhibition rates of each group were calculated by recording the absorbance at 490 nm. This figure shows that LiCl inhibited the survival of C6 glioma cells in a dose-dependent manner in both groups. For each experiment, at least three independent transfection experiments were performed. Data are expressed as mean ± SD (n = 3). P values less than 0.05 were considered statistically significant. *P \ 0.05 for comparisons to pEGFP-N1 transfection groups, respectively Gelatinolytic activity of pro-MMP-2 was detected as one transparent band on the blue background. The gel shown is a representative result of two treatment groups clinically for 50 years in the treatment of bipolar disorder. Inhibition of GSK-3b has recently been proven to be efficient in inhibiting glioma cell. In this study, we found that pEGFP-N1-BmK CT and LiCl had complementary effects towards the inhibition of the secretion level of pro-MMP-2 and proliferation of C6 glioma cells. When C6 cells were treated by LiCl, the accumulation of b-catenin in the cell nucleus was increased in pEGFP-N1 group and pEGFP-N1-BmK CT group.
Transfection of pEGFP-N1-BmK CT into glioma cells will supposedly interact and inhibit the intracellular MMP2. So far, anti-tumor efficiency of all CTXlike small peptides was evaluated in extracellular models, either by adding these peptides to culture medium or injecting into the circulation system of animal models. For the first time, the potential effect of intracellular expression of CTX-like peptide was evaluated and low side effects combination strategy was proposed in this paper. Lithium chloride is the therapeutic agent that has been safely used in clinics for more than 50 years, indicating it is well tolerated by patients. Targeted gene therapy is a future strategy for cancer treatment and promising clinical trials are ongoing using different vectors and genes they are carrying. Based on the results in this paper, we will further screen the best vector for the future in vivo delivery of the gene encoding BmK CT. By doing so, the clinical relevance of this project will be further highlighted. Also, our results implicate the impact of LiCl, BmK CT concomitant treatment on b-catenin, MMP, GSK-3 signaling pathways in glioma cells. The results are consistent with our previous report regarding how addition of BmK CT protein will have synergistic cytotoxic effects towards C6 glioma cells (Fu et al. 2012) . To sum up, these results indicated the antitumor efficacy of LiCl and BmK CT gene therapy and might provide a new therapeutic strategy for glioma cancer. Fig. 3 Lithium chloride and pEGFP-N1-BmK CT inhibited C6 glioma cells migration. Migration distance of two transfection groups was detected at 6, 12 and 24 h after treating with 0-50 mM LiCl, respectively. Migration rate analysis showed that LiCl inhibited C6 glioma cells migration over 24 h. For each experiment, at least three independent transfection experiments were performed. Data are expressed as mean ± SD (n = 3). Statistics were performed between the pEGFP-N1 and pEGFP-N1 ? LiCl Treatment, pEGFP-N1-BmK CT and pEG-FP-N1-BmK CT ? LiCl Treatment at 6, 12 and 24 h, respectively. P values less than 0.05 were considered statistically significant Fig. 4 Effect of lithium chloride and pEGFP-N1-BmK CT on the accumulation of b-catenin in the cell nucleus. C6 glioma cells were transfected with pEGFP-N1, pEGFP-N1-BmK CT and treated with 0-50 mM LiCl, respectively. Western blot analysis showed that LiCl improved the accumulation of bcatenin in cell nucleus Cytotechnology (2016) 68:197-202 201 
